点亮光明 点亮未来

Light up the future

About Us
  • Company introduction
  • Corporate culture
  • Enterprise honor
  • Organizational structure
  • CEO Say
  • Enterprise style

Company introduction

Shanghai Alfors Pharmaceutical Technology Co., Ltd. is a company specializing in the development, production and sales of new generic eye drops. The company's registered capital is 200,000 yuan, located in Xinzhuang Industrial Zone, Minhang District, Shanghai, covering an area of 27,500 square meters. Alfors is a wholly-owned pharmaceutical subsidiary of Hangzhou Foster Group. Since its establishment, the company has successively obtained the drug production license (B) issued by Shanghai Drug Administration, the second-class key enterprise of "Chunshen Pyramid Talent Program" in Minhang District of Shanghai, and applied for more than ten invention patents (including four authorized ones). Obtained the State food and Drug Administration, provincial food and drug administration and other types of approval five. The company's team has been working in the field of eye drops for many years, and the main products are single-dose sterile eye drops without adding preservatives, including: eye drops for controlling myopia of teenagers and children, antibacterial, anti-inflammatory and anti-infection eye drops, and eye drops for treating dry eye diseases.
With the mission of "innovative technology, diligent work to develop safe, effective and reliable ophthalmic formulations to meet clinical needs, benefit patients and create value for society", the company adheres to the quality policy of "safe and effective, continuous improvement, customer satisfaction and user first", positioning itself in the golden track of ophthalmic medicine, and continues to focus on the development of human eye health. With the world's most advanced equipment, first-class technology and excellent quality management, relying on the group's provincial key enterprise research institute, national postdoctoral workstation, advanced experimental instruments and testing equipment, CNAS testing center and other hardware and software conditions, constantly develop safe, high-quality, high-end and cutting-edge ophthalmic products, fulfill social responsibilities, Make a contribution to the cause of eye health in China!

Corporate culture

Enterprise core value
Innovative technology, people-oriented, quality first, excellence
Enterprise mission
With innovative technology and diligent work, we develop safe, effective and reliable ophthalmic preparations to meet clinical needs, benefit patients and create value for society.
Corporate vision
Strive to become the domestic first-class, with independent core technology and intellectual property rights in the field of professional ophthalmology enterprises.

Enterprise honor

Organizational structure

CEO Say

This is an era of rapid development, Alfors was born in this era, we are a young, dynamic enterprise, is a platform full of opportunities and challenges; What the future looks like, we need to describe together.
Facing the bright and future is the goal and belief of every Alfoss. In the past, we have survived many years of preparation, and in the future, we will have a more challenging implementation phase. Alfors will continue to work hard to produce high-quality, high-end and cutting-edge ophthalmic products, strive to promote the rapid development of ophthalmology in China, attach importance to product innovation, increase investment in product research and development, focus on the development of human eye health field, and base itself on the ophthalmic market with excellent strength, so that more eye patients can use our products for the benefit of patients. Fulfill social responsibility while realizing their own value.
Enterprises and employees achieve each other, without the efforts of all employees, enterprises can not sustain long-term development; We are shoulder to shoulder, running forward in the same direction; In the future, we will continue to go forward hand in hand, not afraid of wind and rain, not afraid of difficulties, and firmly contribute to the cause of ophthalmology in China, please believe that with our joint efforts, Alfors will run faster and farther on the golden track of ophthalmic medicine!
Alfors
Chief executive officer

Enterprise style